Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2009

01.11.2009

Postmenopausal Expression Changes of Immune System-Related Genes in Human Bone Tissue

verfasst von: János P. Kósa, Bernadett Balla, János Kiss, János Podani, István Takács, Áron Lazáry, Zsolt Nagy, Krisztián Bácsi, Attila Karsai, Gábor Speer, Péter Lakatos

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The molecular and cellular interactions between the immune system and bone tissue have been established. Sex hormone deficiency after menopause has multifunctional role by influencing growth, differentiation, and metabolism of the skeletal and the immune system.

Discussion

We have used nonparametric and multidimensional expression pattern analyses to determine significantly changed mRNA profile of immune system-associated genes in postmenopausal (POST) and premenopausal (PRE) nonosteoporotic bone. Ten bone tissue samples from POST patients and six bone tissue samples from PRE women were examined in our study. The transcription differences of the selected 50 genes were analyzed in TaqMan probe-based quantitative real-time reverse transcriptase polymerase chain reaction system. Mann–Whitney test indicated significantly downregulated transcription activity of three genes (CD14, HLA-A/MHCI, ITGAM/CD11b) and upregulated expression of six genes (C3, CD86/B7-2, IL-10, IL-6, TGFB3, TNFSF11/RANKL) in postmenopausal bone. According to the canonical variate analysis results, the groups of POST and PRE women are separable by genes coding for cytokines, costimulator molecules, and cell surface receptors involved in antigen presentation and T cell stimulation processes which have high discriminatory power. Based on a complex gene expression pattern analysis of human bone tissue, we could distinguish POST and PRE states from an immunological aspect. Our data might provide further insight into the changes of the intersystem crosstalk between immune and skeletal homeostasis, as well as local immune response in the altered microenvironment of postmenopausal bone.
Literatur
1.
Zurück zum Zitat Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29:403–40.CrossRefPubMed Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29:403–40.CrossRefPubMed
2.
Zurück zum Zitat Walsh MC, Kim N, Kadono Y, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Ann Rev Immunol. 2006;24:33–63.CrossRef Walsh MC, Kim N, Kadono Y, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Ann Rev Immunol. 2006;24:33–63.CrossRef
3.
Zurück zum Zitat Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci. 2006;1068:173–9.CrossRefPubMed Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci. 2006;1068:173–9.CrossRefPubMed
4.
Zurück zum Zitat Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Updat. 2005;11:411–23.CrossRef Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Updat. 2005;11:411–23.CrossRef
5.
Zurück zum Zitat Weitzmann MN, Pacifici R. Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci. 2006;1068:256–74.CrossRefPubMed Weitzmann MN, Pacifici R. Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci. 2006;1068:256–74.CrossRefPubMed
6.
Zurück zum Zitat Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev. 2005;208:194–206.CrossRefPubMed Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev. 2005;208:194–206.CrossRefPubMed
7.
Zurück zum Zitat Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207–27.CrossRefPubMed Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005;208:207–27.CrossRefPubMed
8.
Zurück zum Zitat Safadi FF, Dissanayake IR, Goodman GG, et al. Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs. Endocr. 2000;12:81–8.CrossRef Safadi FF, Dissanayake IR, Goodman GG, et al. Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs. Endocr. 2000;12:81–8.CrossRef
9.
Zurück zum Zitat Deguchi K, Kamada M, Irahara M, et al. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause. 2001;8:266–73.CrossRefPubMed Deguchi K, Kamada M, Irahara M, et al. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause. 2001;8:266–73.CrossRefPubMed
10.
Zurück zum Zitat Kamada M, Irahara M, Maegawa M, et al. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol Obstet Invest. 2001;52:82–8.CrossRefPubMed Kamada M, Irahara M, Maegawa M, et al. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol Obstet Invest. 2001;52:82–8.CrossRefPubMed
11.
Zurück zum Zitat Cenci S, Toraldo G, Weitzmann MN, et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci. 2003;100:10405–10.CrossRefPubMed Cenci S, Toraldo G, Weitzmann MN, et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci. 2003;100:10405–10.CrossRefPubMed
12.
13.
Zurück zum Zitat Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.CrossRefPubMed Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.CrossRefPubMed
14.
Zurück zum Zitat Balla B, Kosa JP, Kiss J, et al. Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int. 2008;82:12–26.CrossRefPubMed Balla B, Kosa JP, Kiss J, et al. Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int. 2008;82:12–26.CrossRefPubMed
15.
Zurück zum Zitat Benayahu D. Estrogen effects on protein expressed by marrow stromal osteoblasts. Biochem Biophys Res Commun. 1997;233:30–5.CrossRefPubMed Benayahu D. Estrogen effects on protein expressed by marrow stromal osteoblasts. Biochem Biophys Res Commun. 1997;233:30–5.CrossRefPubMed
16.
Zurück zum Zitat Podani J. Introduction to the exploration of multivariate biological data. Leiden: Backhuys; 2000. Podani J. Introduction to the exploration of multivariate biological data. Leiden: Backhuys; 2000.
17.
Zurück zum Zitat Podani J. SYN-TAX 2000. User’s manual. Budapest: Scientia; 2001. Podani J. SYN-TAX 2000. User’s manual. Budapest: Scientia; 2001.
18.
19.
Zurück zum Zitat Corthay A. A three-cell model for activation of naive T helper cells. Scand J Immunol. 2006;64:93–6.CrossRefPubMed Corthay A. A three-cell model for activation of naive T helper cells. Scand J Immunol. 2006;64:93–6.CrossRefPubMed
20.
Zurück zum Zitat Schuurhuis DH, Fu N, Ossendorp F, et al. Ins and outs of dendritic cells. Int Arch Allergy Immunol. 2006;140:53–72.CrossRefPubMed Schuurhuis DH, Fu N, Ossendorp F, et al. Ins and outs of dendritic cells. Int Arch Allergy Immunol. 2006;140:53–72.CrossRefPubMed
21.
Zurück zum Zitat Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17–58.CrossRefPubMed Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17–58.CrossRefPubMed
22.
Zurück zum Zitat Hornef MW, Wick MJ, Rhen M, et al. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol. 2002;3:1033–40.CrossRefPubMed Hornef MW, Wick MJ, Rhen M, et al. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol. 2002;3:1033–40.CrossRefPubMed
23.
Zurück zum Zitat Moser M, Murphy KM. Dendritic cell regulation of TH1–TH2 development. Nat Immunol. 2000;1:199–205.CrossRefPubMed Moser M, Murphy KM. Dendritic cell regulation of TH1–TH2 development. Nat Immunol. 2000;1:199–205.CrossRefPubMed
24.
Zurück zum Zitat de Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol. 2005;26:289–307.CrossRefPubMed de Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol. 2005;26:289–307.CrossRefPubMed
25.
Zurück zum Zitat Stopinska-Gluszak U, Waligora J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol. 2006;69:65–75.CrossRefPubMed Stopinska-Gluszak U, Waligora J, Grzela T, et al. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol. 2006;69:65–75.CrossRefPubMed
26.
Zurück zum Zitat Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545–68.CrossRefPubMed Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545–68.CrossRefPubMed
27.
Zurück zum Zitat van Lookeren Campagne M, Wiesmann C, Brown EJ. Macrophage complement receptors and pathogen clearance. Cell Microbiol. 2007;9:2095–102.CrossRefPubMed van Lookeren Campagne M, Wiesmann C, Brown EJ. Macrophage complement receptors and pathogen clearance. Cell Microbiol. 2007;9:2095–102.CrossRefPubMed
28.
Zurück zum Zitat Villiers MB, Perrin-Cocon L, Marche PN, et al. Complement receptors and B lymphocytes. Crit Rev Immunol. 2004;24:465–78.CrossRefPubMed Villiers MB, Perrin-Cocon L, Marche PN, et al. Complement receptors and B lymphocytes. Crit Rev Immunol. 2004;24:465–78.CrossRefPubMed
29.
Zurück zum Zitat Fan JD, Wagner BL, McDonnell DP. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol. 1996;10:1605–16.CrossRefPubMed Fan JD, Wagner BL, McDonnell DP. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol. 1996;10:1605–16.CrossRefPubMed
30.
Zurück zum Zitat Wiethe C, Dittmar K, Doan T, et al. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. J Immunol. 2003;171:4121–30.PubMed Wiethe C, Dittmar K, Doan T, et al. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. J Immunol. 2003;171:4121–30.PubMed
31.
Zurück zum Zitat Salek-Ardakani S, Arens R, Flynn R, et al. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol. 2009;182:2909–18.CrossRefPubMed Salek-Ardakani S, Arens R, Flynn R, et al. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol. 2009;182:2909–18.CrossRefPubMed
32.
Zurück zum Zitat Stanley KT, VanDort C, Motyl C, et al. Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. J Bone Miner Res. 2006;21:29–36.CrossRefPubMed Stanley KT, VanDort C, Motyl C, et al. Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. J Bone Miner Res. 2006;21:29–36.CrossRefPubMed
33.
Zurück zum Zitat Gallo D, Battaglia A, Mantuano E, et al. 17beta-Estradiol and soy phytochemicals selectively induce a type 2 polarization in mesenteric lymph nodes of ovariectomized rats. Menopause. 2008;15:718–25.CrossRefPubMed Gallo D, Battaglia A, Mantuano E, et al. 17beta-Estradiol and soy phytochemicals selectively induce a type 2 polarization in mesenteric lymph nodes of ovariectomized rats. Menopause. 2008;15:718–25.CrossRefPubMed
Metadaten
Titel
Postmenopausal Expression Changes of Immune System-Related Genes in Human Bone Tissue
verfasst von
János P. Kósa
Bernadett Balla
János Kiss
János Podani
István Takács
Áron Lazáry
Zsolt Nagy
Krisztián Bácsi
Attila Karsai
Gábor Speer
Péter Lakatos
Publikationsdatum
01.11.2009
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9321-9

Weitere Artikel der Ausgabe 6/2009

Journal of Clinical Immunology 6/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.